ASX 200 midday update: ResMed disappoints, PointsBet rockets higher

The ASX 200 is having a good day…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

At lunch on Friday, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positive note. The benchmark index is currently up 0.75% to 7,412.7 points.

Here's what is happening on the ASX 200 today:

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements

Image source: Getty Images

ResMed share price falls on quarterly update

The ResMed Inc (ASX: RMD) share price is sinking on Friday after the sleep treatment company's quarterly update fell short of expectations. ResMed reported a 12% increase in revenue to US$864.5 million and a 2% lift in earnings per share to US$1.32. Goldman Sachs notes that the company's revenue and earnings per share missed by 5% and 9%, respectively, versus consensus estimates.

PointsBet shares jump

The PointsBet Holdings Ltd (ASX: PBH) share price is racing higher today thanks to a rebound in the tech sector and a positive reaction to the sports betting company's quarterly update. In respect to the latter, PointsBet reported a 54% increase in turnover to $1,398 million. This reflects a 37% increase in Australian turnover to $579.4 million and a 70% jump in US turnover to $818.6 million.

COVID weighs on Ramsay profits

The Ramsay Health Care Limited (ASX: RHC) share price is trading lower today after the hospital giant revealed that its profits have been hit by COVID restrictions. Ramsay reported third quarter revenue growth of 5.7% to $3,449.2 million but a 59% reduction in net profit to $42.7 million. The latter reflects COVID-related absenteeism, surgical restrictions, and higher operating costs.

Best and worst ASX 200 performers

The best performer on the ASX 200 on Friday has been the PointsBet share price with a gain of 11%. This follows the release of the sports betting company's quarterly update and a rebound in the tech sector. The worst performer has been the ResMed share price with a 5% decline after the sleep treatment company's quarterly update missed expectations.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Pointsbet Holdings Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended Pointsbet Holdings Ltd, Ramsay Health Care Limited, and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Share Market News

Testing again

Read more »

Share Market News

Aaron Test 2

Read more »

Share Market News

Aaron Test

Read more »

Share Market News

JP Test

Read more »

Share Market News

JP Test

Read more »

Portrait of Discovery Fund portfolio managers Mark Devcich and Chris Bainbridge
Share Market News

Test

Portfolio managers Mark Devcich (left) and Chris Bainbridge. Image source: Discovery Fund test test

Read more »

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.
Share Market News

Another ASX 200 company has been hit with a cyber incident. Here's what we know

Hackers have breached the systems of this ASX 200 company.

Read more »

a woman
Broker Notes

5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Read more »